As the hype surrounding cannabis legalization in Canada continues to simmer down, one major bank has pulled the plug on allowing investors to short cannabis stocks.

The Bank of Montreal (BMO) (NYSE:BMO,TSX:BMO) runs a self-directed brokerage called InvestorLine. According to a report from the Financial Post, a number of investors have recently been turned down when trying to open short positions on cannabis stocks.

BMO supposedly told these investors that shorting simply will not be possible for any cannabis stock.

The marijuana stock market has seen its fair share of volatile periods, and short positions have risen as bets against dominating stocks in the space increase.

Shorting a stock is an investment strategy in which an investor or a trader places a bet that a particular company’s share price will drop.

Investopedia describes the action of short selling as when “a position is opened by borrowing shares of a stock or other asset that the investor believes will decrease in value by a set future date — expiration date. The investor then sells these borrowed shares to buyers willing to pay the market price.”

According to the investors who spoke with BMO, they were denied the ability to short cannabis stocks due to market volatility. The move from the bank seems to be recent, with one investor stating that they had opened a short position on CannTrust Holdings (NYSE:CTST,TSX:TRST) through InvestorLine in July.

Other major banks such as the Toronto-Dominion Bank (NYSE:TD,TSX:TD), the National Bank of Canada (TSX:NA,OTC Pink:NTIOF) and the Canadian Imperial Bank of Commerce (NYSE:CM,TSX:CM) remain free of restrictions on cannabis stocks.

EditedOne of the favorites for short sellers has been Tilray (NASDAQ:TLRY), a cannabis producer that has seen one of the most volatile performances since its initial public offering in July 2018.

According to S3 Partners, short sellers of cannabis stocks have had a tough year, but recently have experienced some significant gains.

“Short selling is fairly concentrated to a handful of names, with the top 20 shorts making up over 85 (percent) of the total shorting executed in the sector,” Ihor Dusaniwsky, managing director of predictive analytics at S3 Partners, wrote in a report.

At the Lift & Co. (TSXV:LIFT,OTCQB:LFCOF) Cannabis Business Conference in Vancouver earlier this year, Neal Gilmer, equity research analyst with Haywood Securities, told investors that the prominence of short sellers may be attributed to the high interest the sector has seen with its rampant growth.

Canadian cannabis companies Cronos Group (NASDAQ:CRON,TSX:CRON) and Aphria (NYSE:APHA,TSX:APHA) have faced public short seller attacks from investment research groups as well.

With files from Bryan Mc Govern.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less